CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income/(Loss)
Balance, shares (in shares) at Apr. 03, 2021			50,869
Balance, value at Apr. 03, 2021	$ 731,670		$ 509	$ 602,727		$ 157,981		$ (29,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			74
Employee stock purchase plan	4,209		$ 0	4,209
Exercise of stock options (in shares)			66
Exercise of stock options	2,338		$ 1	2,337
Issuance of restricted stock, net of cancellations (in shares)			115
Issuance of restricted stock, net of cancellations	1		$ 1	0
Share-based compensation expense	24,359			24,359
Net income	43,375					43,375
Other comprehensive income (loss)	3,593							3,593
Balance, shares (in shares) at Apr. 02, 2022			51,124
Balance, value at Apr. 02, 2022	749,424	$ (60,121)	$ 511	572,476	$ (61,156)	202,391	$ 1,035	(25,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			102
Employee stock purchase plan	4,378		$ 0	4,378
Exercise of stock options (in shares)			59
Exercise of stock options	2,638		$ 1	2,637
Shares repurchased (in shares)			(997)
Shares repurchased	(75,000)		$ (10)	(10,366)		(64,624)
Issuance of restricted stock, net of cancellations (in shares)			161
Issuance of restricted stock, net of cancellations	0		$ 2	(2)
Share-based compensation expense	25,583			25,583
Net income	115,401					115,401
Other comprehensive income (loss)	(4,427)							(4,427)
Balance, shares (in shares) at Apr. 01, 2023			50,449
Balance, value at Apr. 01, 2023	817,997		$ 504	594,706		253,168		(30,381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			79
Employee stock purchase plan	5,604		$ 1	5,603
Exercise of stock options (in shares)			163
Exercise of stock options	1,610		$ 2	6,816		(5,208)
Issuance of restricted stock, net of cancellations (in shares)			166
Issuance of restricted stock, net of cancellations	0		$ 2	(2)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	(5,891)		$ (1)	(828)		(5,062)
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation			(69)
Share-based compensation expense	28,332			28,332
Net income	117,558					117,558
Other comprehensive income (loss)	(5,251)							(5,251)
Balance, shares (in shares) at Mar. 30, 2024			50,788
Balance, value at Mar. 30, 2024	$ 959,959		$ 508	$ 634,627		$ 360,456		$ (35,632)